These results suggest that ectopic FOXC2 expression in mouse ovarian cancer cells affects molecular pathways associated with CSC, EMT, angiogenesis, and mural cell differentiation but does not appear to be associated with cancer-endothelial cell trans-differentiation. The gene discussed is FOXC2; the disease is ovarian cancer.